How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

Author:

Pieske Burkert1234,Tschöpe Carsten125,de Boer Rudolf A6ORCID,Fraser Alan G7,Anker Stefan D1258,Donal Erwan9,Edelmann Frank12,Fu Michael10,Guazzi Marco1112,Lam Carolyn S P1314,Lancellotti Patrizio15,Melenovsky Vojtech16,Morris Daniel A1,Nagel Eike1718ORCID,Pieske-Kraigher Elisabeth1,Ponikowski Piotr19,Solomon Scott D20,Vasan Ramachandran S21,Rutten Frans H22ORCID,Voors Adriaan A6,Ruschitzka Frank23,Paulus Walter J24,Seferovic Petar25,Filippatos Gerasimos2627

Affiliation:

1. Department of Internal Medicine and Cardiology, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum

2. German Center for Cardiovascular Research (DZHK), Berlin, Partner Site, Germany

3. Department of Internal Medicine and Cardiology, German Heart Institute, Berlin, Germany

4. Berlin Institute of Health (BIH), Germany

5. Berlin Institute of Health (BIH) Center for Regenerative Therapies (BCRT), Charite, Berlin, Germany

6. University Medical Centre Groningen, University of Groningen, Department of Cardiology, Groningen, the Netherlands

7. School of Medicine, Cardiff University, Cardiff, UK

8. Department of Cardiology and Pneumology, University Medicine Göttingen (UMG), Germany

9. Cardiology and CIC, IT1414, CHU de Rennes LTSI, Université Rennes-1, INSERM 1099, Rennes, France

10. Section of Cardiology, Department of Medicine, Sahlgrenska University Hosptal/Ostra, Göteborg, Sweden

11. Department of Biomedical Sciences for Health, University of Milan, IRCCS, Milan, Italy

12. Department of Cardiology, IRCCS Policlinico, San Donato Milanese, Milan, Italy

13. National Heart Centre, Singapore & Duke-National University of Singapore

14. University Medical Centre Groningen, The Netherlands

15. Department of Cardiology, Heart Valve Clinic, University of Liège Hospital, GIGA Cardiovascular Sciences, CHU Sart Tilman, Liège, Belgium

16. Institute for Clinical and Experimental Medicine - IKEM, Prague, Czech Republic

17. Institute for Experimental and Translational Cardiovascular Imaging, University Hospital Frankfurt

18. German Centre for Cardiovascular Research (DZHK), Partner Site Frankfurt, Germany

19. Medical University, Clinical Military Hospital, Wroclaw, Poland;

20. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

21. Section of Preventive Medicine and Epidemiology and Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA

22. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands

23. University Heart Centre, University Hospital Zurich, Switzerland

24. Department of Physiology and Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, The Netherlands

25. University of Belgrade School of Medicine, Belgrade University Medical Center, Serbia

26. Department of Cardiology, National and Kapodistrian University of Athens Medical School; University Hospital “Attikon”, Athens, Greece

27. University of Cyprus, School of Medicine, Nicosia, Cyprus

Abstract

Abstract Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF) remains a challenge. We recommend a new stepwise diagnostic process, the ‘HFA–PEFF diagnostic algorithm’. Step 1 (P=Pre-test assessment) is typically performed in the ambulatory setting and includes assessment for HF symptoms and signs, typical clinical demographics (obesity, hypertension, diabetes mellitus, elderly, atrial fibrillation), and diagnostic laboratory tests, electrocardiogram, and echocardiography. In the absence of overt non-cardiac causes of breathlessness, HFpEF can be suspected if there is a normal left ventricular ejection fraction, no significant heart valve disease or cardiac ischaemia, and at least one typical risk factor. Elevated natriuretic peptides support, but normal levels do not exclude a diagnosis of HFpEF. The second step (E: Echocardiography and Natriuretic Peptide Score) requires comprehensive echocardiography and is typically performed by a cardiologist. Measures include mitral annular early diastolic velocity (e′), left ventricular (LV) filling pressure estimated using E/e′, left atrial volume index, LV mass index, LV relative wall thickness, tricuspid regurgitation velocity, LV global longitudinal systolic strain, and serum natriuretic peptide levels. Major (2 points) and Minor (1 point) criteria were defined from these measures. A score ≥5 points implies definite HFpEF; ≤1 point makes HFpEF unlikely. An intermediate score (2–4 points) implies diagnostic uncertainty, in which case Step 3 (F1: Functional testing) is recommended with echocardiographic or invasive haemodynamic exercise stress tests. Step 4 (F2: Final aetiology) is recommended to establish a possible specific cause of HFpEF or alternative explanations. Further research is needed for a better classification of HFpEF.

Funder

Heart Failure Association

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3